United States · 
Who invested in Flare Therapeutics?
Flare Therapeutics's investors include Invus, Eli Lilly, Casdin Capital and Novartis.
United States · Series B startup
Who invested in Flare Therapeutics
Funding summaryUpdated 26 Oct 2026
$123Mraised across 1 round since 2023, from 1 source
- Latest round
- Series B, $123MMar 2023
- Investors
- 4
The rounds
- Mar 2023
Founders and team
From Flare Therapeutics's own website: 6 on the team.
- Anna ProtopapasChief Executive Officer and Board Member
- Brian C. DeSchuytnerChief Financial Officer & Chief Business Officer
- Tracy L. SmithChief Human Resources Officer
- Aaron DavisBoard Member
- Jigar RaythathaBoard Member
- Kanishka PothulaBoard Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Flare Therapeutics
How much has Flare Therapeutics raised?
Flare Therapeutics has raised $123M across 1 round since 2023.
When did Flare Therapeutics last raise?
Flare Therapeutics's most recent round was a Series B of $123M in Mar 2023.
What was Flare Therapeutics's biggest round?
Its most recent round, $123M in Mar 2023, is also its largest on record.
Who backed Flare Therapeutics first?
Flare Therapeutics's first round on record, in Mar 2023, was backed by Invus, Eli Lilly and Casdin Capital and 1 others.
What stage is Flare Therapeutics at?
Flare Therapeutics's latest named round is a Series B, in Mar 2023.
Where is Flare Therapeutics based?
Flare Therapeutics is based in the United States.
Companies like Flare Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.